search
Back to results

Ketofol for Preventing Postoperative Delirium in Elderly Patients

Primary Purpose

Delirium on Emergence

Status
Completed
Phase
Phase 4
Locations
Egypt
Study Type
Interventional
Intervention
ketofol
dexmedetomidine
normal saline
Sponsored by
Zagazig University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Delirium on Emergence focused on measuring ketofol, dexmedetomidine, post operative delirium, elderly patients

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient acceptance.
  • Age ≥ 60 years old.
  • American society of anesthesia (ASA) (II-III).
  • Gender: males &females
  • BMI < 35kg/m2.
  • able to communicate verbally.
  • Scheduled for exploration surgery for intestinal obstruction under general anesthesia of at least 60 min duration

Exclusion Criteria:

  • Patient refusal.
  • Patients with delirium prior to surgery.
  • Patients with drug misuse history or taking anti-psychotic drugs.
  • Previous hospitalization within 3 months.
  • Legal blindness, severe deafness.
  • History of Acute cerebrovascular conditions; stroke or transient ischemic attack.
  • Patients who could not be prepared with proper fluid resuscitation, electrolyte and acid-base correction prior to surgery.
  • Patients who could be discharged from the intensive care unit (ICU) within two days.
  • Patients with a known history of allergy to study drugs

Sites / Locations

  • Faculty of medicine, zagazig university

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Placebo Comparator

Active Comparator

Active Comparator

Arm Label

Control group

ketofol group

dexmedetomidine group

Arm Description

21 ml of normal saline 0.9% will be I.V continuously infused fifteen minutes after induction of anesthesia up to two hours postoperatively.

21 ml of a mixture of (ketamine and propofol) will be I.V continuously infused fifteen minutes after induction of anesthesia up to two hours postoperatively

21 ml of a mixture of (dexmedetomidine diluted with normal saline 0.9%) will be I.V continuously infused fifteen minutes after induction of anesthesia up to two hours postoperatively

Outcomes

Primary Outcome Measures

incidence of post operative delirium
Patients will be assessed for postoperative delirium using Confusion Assessment Method (CAM), or the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)

Secondary Outcome Measures

changes of pain assessment
Visual analogue scale
changes of hemodynamics
by non invasive blood pressure

Full Information

First Posted
March 22, 2021
Last Updated
July 30, 2023
Sponsor
Zagazig University
search

1. Study Identification

Unique Protocol Identification Number
NCT04816162
Brief Title
Ketofol for Preventing Postoperative Delirium in Elderly Patients
Official Title
Ketofol vs Dexmedetomidine for Preventing Post-operative Delirium in Elderly Patients Undergoing Intestinal Obstruction Surgeries. A Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
March 25, 2021 (Actual)
Primary Completion Date
November 1, 2022 (Actual)
Study Completion Date
February 1, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Zagazig University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Delirium is a cognitive disturbance characterized by acute and fluctuating impairment in attention and awareness. Although its incidence in the general surgical population is 2-3%, it has been reported to occur in up to 10-80% of high-risk patient groups. In addition, the occurrence of postoperative delirium is associated with considerably raised morbidity and mortality and increased healthcare resource expenditure. In the general patient population, no prophylactic pharmacologic treatment has shown widespread effectiveness in preventing delirium. Several studies have failed to find a magic pharmacologic bullet for preventing delirium-ketamine, haloperidol, propofol, antipsychotic and benzodiazepine drugs have recently tested without a clear result of its effectiveness. Dexmedetomidine is an attractive pharmacologic option because of its biological plausibility in modifying several known contributors to delirium. Up to investigators' knowledge, there is no study done to compare the effect of infusion of dexmedetomidine and ketofol mixture as prophylactic agents for high-risk patients as elderly patients who undergoing high-risk surgery such as intestinal obstruction surgery against postoperative delirium occurrence.
Detailed Description
Small bowel obstruction (SBO) is one of the most frequent causes of general emergency surgery in elderly patients, approximately 10-12% of adult patients above 65 years presenting with acute abdominal pain at the emergency department (ED) is diagnosed as SBO. Small bowel obstruction is complicated with dehydration, malnutrition, electrolyte and acid-base disturbance, as well as insertion of many catheters as nasogastric tube, triple-lumen tube, and foley's catheter, besides multiple drugs intake due to the associated comorbidities; all of these factors increase the risk of developing POD ]. Delirium is defined as acute onset of fluctuating disturbance of consciousness with reduced ability to focus, alteration of attention, perceptual abnormalities, circadian disruption, a decline in cognitive function (orientation, memory speech, thinking), and psychomotor disturbances. POD commonly occurs between postoperative days 2-5, and it may be hypoactive, hyperactive, or mixed, based on psychomotor clinical features. The incidence rate of postoperative delirium(POD) varies between 9% and 87% in elderly patients, depending on the patients' population and degree of operative stress. Postoperative delirium develops in the elderly due to multiple risk factors that can be separated into patient-related and operation-related risk factors. Established patient-specific risk factors include pre-existing dementia (appears to be the strongest predictor for the occurrence of POD), older age, functional impairment, greater co-morbidities, and psychopathological symptoms. Operation-specific risk factors for POD are based on the degree of operative stress, any type of iatrogenic event including medication adverse effects (Common drugs that may precipitate delirium in the elderly include antihistamines, anticholinergics, chemotherapeutic agents, dopamine agonists, benzodiazepines, opioid analgesics, steroids, and psychostimulants), physical restraint, urinary catheterization, hospital-acquired infection, dehydration and malnutrition, and admission to the intensive care unit (ICU). The risk factors for developing POD are additive therefore, recognizing those with multiple risk factors should trigger environmental and supportive measures implementation that have been proven to prevent the onset and shorten the duration of POD because POD is associated with poor outcomes such as functional decline, longer hospitalization, greater costs, a greater need for rehabilitation and home healthcare services after discharge and higher mortality. Ketofol which is a mixture of ketamine and propofol gains increasing interest as an agent for procedural sedation and analgesia for producing a more stable hemodynamic and respiratory profile as Ketamine and propofol appear to counter each other's adverse effects; sympathomimetic effects of ketamine and dose-dependent hypotension and respiratory depression of propofol. Ketofol has been used in different mixed ratios (1:1-1:10) and has proven effective in reducing postoperative agitation in children in several studies as well. Dexmedetomidine, a highly selective alpha-2 adrenoreceptor (α2) agonist, has been widely used in surgical patients and has positive sedation, anti-anxiety, and analgesic effects. The mechanism of action of dexmedetomidine is unique compared with traditionally administered sedative agents due to its lack of activity at the gamma-aminobutyric acid (GABA) receptor and missing anticholinergic activity.1that may contribute to pathophysiological explanations of the development of delirium 'neurotransmitter hypothesis' and include dysfunction of cholinergic transmission. The investigators hypothesized that administration of ketofol following induction of general anesthesia, would reduce the incidence of emergence delirium and postoperative delirium, and has a comparable effect to dexmedetomidine on investigators' groups of high-risk elderly patients undergoing urgent exploration of intestinal obstruction.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delirium on Emergence
Keywords
ketofol, dexmedetomidine, post operative delirium, elderly patients

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
A computer-generated table will be used to divide patients equally into three study groups In group C (control group):21 ml of normal saline 0.9% will be I.V infused at a rate of 0.3-0.4 mg/kg/h to the patient. In group K: ketofol (a mixture of ketamine and propofol will be prepared in a ratio of (1:4) respectively), will be I.V infused at a rate of 0.3-0.4 mg/kg/h to the patient. In group D: adding dexmedetomidine 2 ml (200 µg) to 19 ml of 0.9% normal saline to start I.V infusion to the patient
Masking
ParticipantOutcomes Assessor
Masking Description
double-blinded(participants and outcome assessors)
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
Placebo Comparator
Arm Description
21 ml of normal saline 0.9% will be I.V continuously infused fifteen minutes after induction of anesthesia up to two hours postoperatively.
Arm Title
ketofol group
Arm Type
Active Comparator
Arm Description
21 ml of a mixture of (ketamine and propofol) will be I.V continuously infused fifteen minutes after induction of anesthesia up to two hours postoperatively
Arm Title
dexmedetomidine group
Arm Type
Active Comparator
Arm Description
21 ml of a mixture of (dexmedetomidine diluted with normal saline 0.9%) will be I.V continuously infused fifteen minutes after induction of anesthesia up to two hours postoperatively
Intervention Type
Drug
Intervention Name(s)
ketofol
Other Intervention Name(s)
a mixture of propofol and ketamine
Intervention Description
prepared in a ratio of (1:4) respectively), where 1ml of ketamine will be added to 20 ml of propofol in a syringe pump
Intervention Type
Drug
Intervention Name(s)
dexmedetomidine
Other Intervention Name(s)
precedex
Intervention Description
2 ml (200 µg) of dexmedetomidine added to 0.9% normal saline in a syringe pump
Intervention Type
Other
Intervention Name(s)
normal saline
Intervention Description
normal saline 0.9% in a syringe pump
Primary Outcome Measure Information:
Title
incidence of post operative delirium
Description
Patients will be assessed for postoperative delirium using Confusion Assessment Method (CAM), or the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)
Time Frame
up to first three postoperative days
Secondary Outcome Measure Information:
Title
changes of pain assessment
Description
Visual analogue scale
Time Frame
30 minutes, 1 hour, 2, 4, 18, 12, 24 hours postoperatively
Title
changes of hemodynamics
Description
by non invasive blood pressure
Time Frame
immediately prior to surgery, intraoperative (after starting infusion of study drug, then every 10 minute till end of surgery), later on they will be measured every 15 min postoperatively up to two hours postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient acceptance. Age ≥ 60 years old. American society of anesthesia (ASA) (II-III). Gender: males &females BMI < 35kg/m2. able to communicate verbally. Scheduled for exploration surgery for intestinal obstruction under general anesthesia of at least 60 min duration Exclusion Criteria: Patient refusal. Patients with delirium prior to surgery. Patients with drug misuse history or taking anti-psychotic drugs. Previous hospitalization within 3 months. Legal blindness, severe deafness. History of Acute cerebrovascular conditions; stroke or transient ischemic attack. Patients who could not be prepared with proper fluid resuscitation, electrolyte and acid-base correction prior to surgery. Patients who could be discharged from the intensive care unit (ICU) within two days. Patients with a known history of allergy to study drugs
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shereen E Abd Ellatif, MD
Organizational Affiliation
faculty of human medicine,zagazig university
Official's Role
Principal Investigator
Facility Information:
Facility Name
Faculty of medicine, zagazig university
City
Zagazig
State/Province
Alsharqia
ZIP/Postal Code
4115
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
planned after the completion of the study and publication
IPD Sharing Time Frame
planned after the completion of the study and publication
IPD Sharing Access Criteria
contact with principal investigator
Citations:
PubMed Identifier
25635203
Citation
Spangler R, Van Pham T, Khoujah D, Martinez JP. Abdominal emergencies in the geriatric patient. Int J Emerg Med. 2014 Oct 21;7:43. doi: 10.1186/s12245-014-0043-2. eCollection 2014.
Results Reference
background
PubMed Identifier
30377439
Citation
Ozturk E, van Iersel M, Stommel MM, Schoon Y, Ten Broek RR, van Goor H. Small bowel obstruction in the elderly: a plea for comprehensive acute geriatric care. World J Emerg Surg. 2018 Oct 20;13:48. doi: 10.1186/s13017-018-0208-z. eCollection 2018.
Results Reference
background
PubMed Identifier
22826531
Citation
Dale O, Somogyi AA, Li Y, Sullivan T, Shavit Y. Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis. Anesth Analg. 2012 Oct;115(4):934-43. doi: 10.1213/ANE.0b013e3182662e30. Epub 2012 Jul 23.
Results Reference
background
PubMed Identifier
19567759
Citation
Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009 May-Jun;50(3):206-17. doi: 10.1176/appi.psy.50.3.206.
Results Reference
background
PubMed Identifier
30707179
Citation
Li WX, Luo RY, Chen C, Li X, Ao JS, Liu Y, Yin YQ. Effects of propofol, dexmedetomidine, and midazolam on postoperative cognitive dysfunction in elderly patients: a randomized controlled preliminary trial. Chin Med J (Engl). 2019 Feb;132(4):437-445. doi: 10.1097/CM9.0000000000000098.
Results Reference
background
PubMed Identifier
25909406
Citation
Smischney NJ, Hoskote SS, Gallo de Moraes A, Racedo Africano CJ, Carrera PM, Tedja R, Pannu JK, Hassebroek EC, Reddy DR, Hinds RF, Thakur L. Ketamine/propofol admixture (ketofol) at induction in the critically ill against etomidate (KEEP PACE trial): study protocol for a randomized controlled trial. Trials. 2015 Apr 21;16:177. doi: 10.1186/s13063-015-0687-0.
Results Reference
background

Learn more about this trial

Ketofol for Preventing Postoperative Delirium in Elderly Patients

We'll reach out to this number within 24 hrs